Background: A nationwide needs assessment survey identified suboptimal knowledge of insulin pumps and continuous glucose monitors (CGM) among pediatric endocrinology fellows.

Objectives: We developed and assessed the impact of an online, spaced education curriculum- Technology Knowledge Optimization in type 1 diabetes (TeKnO T1D)- on fellows’ knowledge of these technologies.

Methods: Endocrine fellows nationwide were invited to participate in this ongoing prospective, randomized cross over study. The pretest assessment included 20 multiple choice questions. A commercially available electronic spaced education platform (QStream) was used to deliver the material. The posttest assessment was identical and also included two questions assessing reactions to the curriculum. A linear multivariable regression was used to compare the deltas (pre-post) between the two groups adjusted for fellowship year and other covariates.

Results: Sixty-one fellows completed the pretest assessment. To date, 21 (68%) and 18 (60%) fellows have completed the pump and CGM curricula, respectively. Fellows who received the pump curriculum had a 41% greater mean improvement on the posttest questions focused on insulin pumps as compared to the fellow who completed the CGM curriculum (95% CI, 1.05, 1.88). Fellows who completed the CGM curriculum had a 70% greater mean improvement on the post-test questions focused on CGMs as compared to fellows who completed the pump curriculum (95% CI, 1.22, 1.37). The greatest improvements were seen in the following topics: interpretation of CGM trend arrows, pump management during exercise, managing pump disconnections, and unique features of different CGM systems. 97% of fellows agreed or strongly agreed that they enjoyed TeKnO T1D.

Conclusion: TeKnO T1D is an effective, enjoyable way to improve T1D technology knowledge across a large group of geographically dispersed fellows. This learning modality may also have applications for other healthcare professionals as well as patients and families.

Disclosure

B. Marks: None. G. Waldman: None. D.E. Stafford: None. K. Garvey: None. J. Nagler: None. J.I. Wolfsdorf: Other Relationship; Self; UpToDate, Xeris Pharmaceuticals, Inc.

Funding

Pediatric Endocrine Society; Boston Children's Hospital

© 2019 by the American Diabetes Association.
2019
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.